Literature DB >> 24796520

Molecular and cellular mechanisms of heterotopic ossification.

Diana M Ramirez1, Melissa R Ramirez2, Anthony M Reginato3, Damian Medici4.   

Abstract

Heterotopic ossification (HO) is a debilitating condition in which cartilage and bone forms in soft tissues such as muscle, tendon, and ligament causing immobility. This process is induced by inflammation associated with traumatic injury. In an extremely rare genetic disorder called fibrodysplasia ossificans progessiva (FOP), a combination of inflammation associated with minor soft tissue injuries and a hereditary genetic mutation causes massive HO that progressively worsens throughout the patients' lifetime leading to the formation of an ectopic skeleton. An activating mutation in the BMP type I receptor ALK2 has been shown to contribute to the heterotopic lesions in FOP patients, yet recent studies have shown that other events are required to stimulate HO including activation of sensory neurons, mast cell degranulation, lymphocyte infiltration, skeletal myocyte cell death, and endothelial-mesenchymal transition (EndMT). In this review, we discuss the recent evidence and mechanistic data that describe the cellular and molecular mechanisms that give rise to heterotopic bone.

Entities:  

Mesh:

Year:  2014        PMID: 24796520      PMCID: PMC4372050          DOI: 10.14670/HH-29.1281

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  31 in total

1.  A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date.

Authors:  Celia L Gregson; Peter Hollingworth; Martin Williams; Kirsten A Petrie; Alex N Bullock; Matthew A Brown; Jon H Tobias; James T Triffitt
Journal:  Bone       Date:  2010-10-29       Impact factor: 4.398

2.  Bone morphogenetic protein 2/4 in early fibromatous lesions of fibrodysplasia ossificans progressiva.

Authors:  F H Gannon; F S Kaplan; E Olmsted; G C Finkel; M A Zasloff; E Shore
Journal:  Hum Pathol       Date:  1997-03       Impact factor: 3.466

3.  A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.

Authors:  Eileen M Shore; Meiqi Xu; George J Feldman; David A Fenstermacher; Tae-Joon Cho; In Ho Choi; J Michael Connor; Patricia Delai; David L Glaser; Martine LeMerrer; Rolf Morhart; John G Rogers; Roger Smith; James T Triffitt; J Andoni Urtizberea; Michael Zasloff; Matthew A Brown; Frederick S Kaplan
Journal:  Nat Genet       Date:  2006-04-23       Impact factor: 38.330

4.  Pulmonary and cardiac function in advanced fibrodysplasia ossificans progressiva.

Authors:  W G Kussmaul; A N Esmail; Y Sagar; J Ross; S Gregory; F S Kaplan
Journal:  Clin Orthop Relat Res       Date:  1998-01       Impact factor: 4.176

5.  Substance P signaling mediates BMP-dependent heterotopic ossification.

Authors:  Lixin Kan; Vitali Y Lounev; Robert J Pignolo; Lishu Duan; Yijie Liu; Stuart R Stock; Tammy L McGuire; Bao Lu; Norma P Gerard; Eileen M Shore; Frederick S Kaplan; John A Kessler
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

6.  Fibrodysplasia ossificans progressiva: middle-age onset of heterotopic ossification from a unique missense mutation (c.974G>C, p.G325A) in ACVR1.

Authors:  Michael P Whyte; Deborah Wenkert; Jennifer L Demertzis; Edward F DiCarlo; Erica Westenberg; Steven Mumm
Journal:  J Bone Miner Res       Date:  2012-03       Impact factor: 6.741

7.  A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H).

Authors:  Hirokazu Furuya; Koji Ikezoe; Lixiang Wang; Yasumasa Ohyagi; Kyoko Motomura; Naoki Fujii; Jun-Ichi Kira; Yasuyuki Fukumaki
Journal:  Am J Med Genet A       Date:  2008-02-15       Impact factor: 2.802

8.  Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients.

Authors:  J M Connor; D A Evans
Journal:  J Bone Joint Surg Br       Date:  1982

9.  Glast-expressing progenitor cells contribute to heterotopic ossification.

Authors:  Lixin Kan; Chian-Yu Peng; Tammy L McGuire; John A Kessler
Journal:  Bone       Date:  2012-12-20       Impact factor: 4.398

10.  Novel mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients.

Authors:  Kirsten A Petrie; Wen Hwa Lee; Alex N Bullock; Jenny J Pointon; Roger Smith; R Graham G Russell; Matthew A Brown; B Paul Wordsworth; James T Triffitt
Journal:  PLoS One       Date:  2009-03-30       Impact factor: 3.240

View more
  17 in total

1.  AMPK downregulates ALK2 via increasing the interaction between Smurf1 and Smad6, leading to inhibition of osteogenic differentiation.

Authors:  Hui Lin; Ying Ying; Yuan-Yuan Wang; Gang Wang; Shan-Shan Jiang; Deqinag Huang; Lingyu Luo; Ye-Guang Chen; Louis C Gerstenfeld; Zhijun Luo
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-08-25       Impact factor: 4.739

2.  Crosstalk between substance P and calcitonin gene-related peptide during heterotopic ossification in murine Achilles tendon.

Authors:  Ceren Tuzmen; Kostas Verdelis; Lee Weiss; Phil Campbell
Journal:  J Orthop Res       Date:  2018-01-05       Impact factor: 3.494

Review 3.  Cell death, clearance and immunity in the skeletal muscle.

Authors:  C Sciorati; E Rigamonti; A A Manfredi; P Rovere-Querini
Journal:  Cell Death Differ       Date:  2016-02-12       Impact factor: 15.828

Review 4.  Tendon regeneration and scar formation: The concept of scarless healing.

Authors:  Leesa M Galatz; Louis Gerstenfeld; Ellen Heber-Katz; Scott A Rodeo
Journal:  J Orthop Res       Date:  2015-04-27       Impact factor: 3.494

Review 5.  Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases.

Authors:  Sonsoles Piera-Velazquez; Sergio A Jimenez
Journal:  Physiol Rev       Date:  2019-04-01       Impact factor: 37.312

Review 6.  Pathophysiology and Emerging Molecular Therapeutic Targets in Heterotopic Ossification.

Authors:  Favour Felix-Ilemhenbhio; George A E Pickering; Endre Kiss-Toth; Jeremy Mark Wilkinson
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

7.  Mkx-Deficient Mice Exhibit Hedgehog Signaling-Dependent Ectopic Ossification in the Achilles Tendons.

Authors:  Han Liu; Jingyue Xu; Rulang Jiang
Journal:  J Bone Miner Res       Date:  2019-02-25       Impact factor: 6.741

Review 8.  Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?

Authors:  Sergio A Jimenez; Sonsoles Piera-Velazquez
Journal:  Matrix Biol       Date:  2016-01-22       Impact factor: 11.583

9.  Predicting Heterotopic Ossification Early After Burn Injuries: A Risk Scoring System.

Authors:  Jeffrey C Schneider; Laura C Simko; Richard Goldstein; Vivian L Shie; Betty Chernack; Benjamin Levi; Prakash Jayakumar; Karen J Kowalske; David N Herndon; Nicole S Gibran; Colleen M Ryan
Journal:  Ann Surg       Date:  2017-07       Impact factor: 13.787

Review 10.  Skeletal and cardiac muscle pericytes: Functions and therapeutic potential.

Authors:  Iain R Murray; James E Baily; William C W Chen; Ayelet Dar; Zaniah N Gonzalez; Andrew R Jensen; Frank A Petrigliano; Arjun Deb; Neil C Henderson
Journal:  Pharmacol Ther       Date:  2016-09-02       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.